Dr. Benjamin Fegale, MD

Dr. Fegale practices at Mission Surgical Group in Riverside, California.

Dr. Fegale's NPI, 1972982239, was assigned on May 20, 2015. Dr. Fegale graduated from Loma Linda University School Of Medicine in 2015. Dr. Fegale holds California license A149972.

Dr. Fegale's primary practice is Mission Surgical Group, at 3660 Park Sierra Dr, Riverside, CA 92505 in Riverside County. The practice phone is (951) 278-8870.

Dr. Fegale's primary practice is Mission Surgical Group in Riverside, California. Dr. Fegale is also affiliated with Riverside Community Hospital. The medical group on file is Mission Surgical Clinic. Dmand AI also links Dr. Fegale to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fegale practices, 4 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Fegale's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Fegale is board certified in surgery by the American Board of Surgery. Dr. Fegale is licensed in California.

Dmand AI lists blood vessel access for dialysis, carotid revascularization, leg revascularization, peripheral vascular disease, varicose veins and varicose vein treatment among the conditions Dr. Fegale treats.

CMS data shows 558 Medicare services from Dr. Fegale across 20 procedure codes in 2024, for 168 Medicare patients. Medicare paid $151,768 for them.

CMS counts 168 Medicare patients who saw Dr. Fegale in 2024. The largest group is 65 to 74, with 71 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 64% are also on Medicaid. Their average risk score is 4.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fegale's median patient age at 65, with 56% women.

In 2024, Dr. Fegale wrote 218 Medicare Part D claims for 89 patients. 86% of them were for generic drugs. CMS names the drug for 171 of them, across 6 drugs with 11 or more claims each, at $13,333 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Fegale for performance year 2024, reported as part of a group. CMS counts 23 procedures of leg revascularization (restoring blood flow) by Dr. Fegale, more than 83% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 87 general payments to Dr. Fegale from 22 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 90% of the total. Medtronic, Inc. paid the most, $897.

Dr. Fegale graduated from Loma Linda University School Of Medicine in 2015.

Dr. Fegale is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.